✦ LIBER ✦

O-73 High dose, twice-daily thoracic radiotherapy (TRT) with daily chemotherapy in limited stage small cell lung cancer

✍ Scribed by Bonner, James A.; Hillman, Shauna; Vigliotti, Antonio P.G.; Kozelsky, Timothy F.; Marks, Randolph S.; Frank, Albert R.; Graham, David L.; Sloan, Jeff A.; Mailliard, James E.; Jett, James R.

Book ID: 118571464
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 177 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91731-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alternating chemotherapy and twice-daily

Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small cell lung cancer: a report of 134 patients

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Concurrent cisplatin/etoposide chemother

Concurrent cisplatin/etoposide chemotherapy plus twice daily thoracic radiotherapy in limited stage small cell lung cancer: a phase II study

✍ Mennecier, Bertrand; Jacoulet, Pascale; Dubiez, André; Westeel, Virginie; Bosset 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Twice-Daily Compared with Once-Daily Tho

Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

✍ Turrisi, Andrew T.; Kim, Kyungmann; Blum, Ronald; Sause, William T.; Livingston, 📂 Article 📅 1999 🏛 Massachusetts Medical Society 🌐 English ⚖ 102 KB

Cisplatin/etoposide chemotherapy combine

Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: A clinical Phase II trial

✍ Gui-Yuan Chen; Guo-Liang Jiang; Li-Juan Wang; Hao Qian; Xiao-Long Fu; Huajun Yan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Alternating chemotherapy and twice-daily

Alternating chemotherapy and twice-daily thoracic radiotherapy in limited- stage small-cell lung cancer: A pilot study of the Eastern Cooperative Oncology Group

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 301 KB

Feasibility and toxicity report from a p

Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited-stage small cell lung cancer (LS-SCLC)

✍ Sheikh, H.; Blackhall, F.; Lorigan, P.; Taylor, P.; Ashcroft, L.; Rowbottom, C.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 129 KB